Acinetobacter baumannii is a notorious Gram-negative healthcare-associated (nosocomial
and community-acquired) bacterial pathogen that causes a high mortality rate (up to 70%) …

Acinetobacter baumannii has become an important cause of human infections, most notably
in the hospital setting. In addition, the global dissemination of multidrug resistant strains has …

Acinetobacter baumannii has been a major cause of nosocomial infections for decades. The
absence of an available vaccine coupled with emerging multidrug resistance has prevented …

Acinetobacter baumannii has emerged as one of major nosocomial pathogen and global
emergence of multidrug-resistant strains has become a challenge for developing effective …

Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten
public health. The formidable adaptability and resistance of this opportunistic pathogen have …

Introduction Healthcare-associated infections caused by multidrug-resistant Acinetobacter
baumannii are becoming alarming worldwide. However, the pipeline of new antibiotics is …

ABSTRACT In 2017, the World Health Organization (WHO) named A. baumannii as one of
the three antibiotic-resistant bacterial species on its list of global priority pathogens in dire …

Acinetobacter baumannii is a gram-negative bacterium and a crucial opportunistic pathogen
in hospitals. A. baumannii infection has become a challenging problem in clinical practice …

Acinetobacter baumannii is a Gram-negative, opportunistic pathogen that causes
nosocomial infection with a high mortality rate in immunocompromised individuals. With the …

Acinetobacter baumannii is a major cause of healthcare-associated infections worldwide
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …